TREM2在阿尔茨海默病及其他神经退行性疾病中的作用
本文综述了髓系细胞触发受体2(TREM2)基因罕见变异与阿尔茨海默病风险的关系:TREM2变异可使个体患阿尔茨海默病的风险最高增至三倍。TREM2与阿尔茨海默病的关联支持免疫和炎症通路参与疾病病因,而非疾病的结果。TREM2变异还可导致多囊性脂膜性骨发育不良伴硬化性白质脑病和额颞叶痴呆。
要点
- TREM2罕见变异可使个体患阿尔茨海默病的风险最高增至三倍。
- TREM2与阿尔茨海默病的关联支持免疫和炎症通路参与病因,而非疾病结果。
- TREM2变异频率低,难以建立稳健的基因型-表型关联,但此类研究对开发新治疗手段至关重要。
核心结论
- TREM2罕见变异可使个体患阿尔茨海默病的风险最高增至三倍,支持免疫和炎症通路参与阿尔茨海默病的病因而非作为疾病的结果。
- TREM2变异与阿尔茨海默病相关的变异导致TREM2蛋白部分功能丧失,并改变小胶质细胞的行为,包括其对淀粉样斑块的反应。
- TREM2变异已被证明可导致多囊性脂膜性骨发育不良伴硬化性白质脑病和额颞叶痴呆。
- TREM2变异频率低使稳健的基因型-表型关联难以建立,但此类研究对全面理解TREM2在不同神经系统疾病中的作用至关重要,最终目标是开发新的治疗手段。
研究设计与样本
- 本文为综述,检索范围原文未报告。
主要发现
- TREM2罕见变异可使个体患阿尔茨海默病的风险最高增至三倍。
- TREM2是与阿尔茨海默病相关的变异导致TREM2蛋白部分功能丧失,并改变小胶质细胞的行为,包括其对淀粉样斑块的反应。
- TREM2变异已被证明可导致多囊性脂膜性骨发育不良伴硬化性白质脑病和额颞叶痴呆。
临床怎么用
- 原文未据此给出推荐。
局限性
- TREM2变异频率低使稳健的基因型-表型关联难以建立。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Alzheimer's disease is a genetically complex disorder; rare variants in the triggering receptor expressed on myeloid cells 2 (TREM2) gene have been shown to as much as triple an individual's risk of developing Alzheimer's disease. TREM2 is a transmembrane receptor expressed in cells of the myeloid lineage, and its association with Alzheimer's disease supports the involvement of immune and inflammatory pathways in the cause of the disease, rather than as a consequence of the disease. TREM2 variants associated with Alzheimer's disease induce partial loss of function of the TREM2 protein and alter the behaviour of microglial cells, including their response to amyloid plaques. TREM2 variants have also been shown to cause polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy and frontotemporal dementia. Although the low frequency of TREM2 variants makes it difficult to establish robust genotype-phenotype correlations, such studies are essential to enable a comprehensive understanding of the role of TREM2 in different neurological diseases, with the ultimate goal of developing novel therapeutic approaches.
引用
- Carmona S, Zahs K, Wu E, et al. The role of TREM2 in Alzheimer's disease and other neurodegenerative disorders. Lancet Neurol. 2018. PMID: 30033062. doi:10.1016/S1474-4422(18)30232-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。